Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 2, 2023
Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity
Shuangshuang Gu, Jinsong Zhang, Xiaxia Han, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 29, 2018
Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes
Jiehua Wang, Min Dai, Yange Cui, et al.
Cancer Letters
|
May 2, 2015
MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition
Jing Tang, Liang Li, Wentao Huang, et al.
Gut
|
May 24, 2019
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
Dai-Min Xiang, Wen Sun, Tengfei Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 19, 2025
Trio whole exome sequencing in Chinese childhood-onset lupus reveals novel candidate genes
Jianyang Ma, Yuting Qin, Soon-Min Hong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 17, 2022
Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus
Guojun Hou, Tian Zhou, Ning Xu, et al.
Frontiers in Immunology
|
May 28, 2019
Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis
Zhuojun Liao, Zhizhong Ye, Zhixin Xue, et al.
Gut
|
February 11, 2016
Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis
Yingcheng Yang, Ximeng Lin, Xinyuan Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2015
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 17, 2016
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 2, 2023
Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity
Shuangshuang Gu, Jinsong Zhang, Xiaxia Han, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 29, 2018
Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes
Jiehua Wang, Min Dai, Yange Cui, et al.
Cancer Letters
|
May 2, 2015
MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition
Jing Tang, Liang Li, Wentao Huang, et al.
Gut
|
May 24, 2019
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
Dai-Min Xiang, Wen Sun, Tengfei Zhou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 19, 2025
Trio whole exome sequencing in Chinese childhood-onset lupus reveals novel candidate genes
Jianyang Ma, Yuting Qin, Soon-Min Hong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 17, 2022
Integrative Functional Genomics Identifies Systemic Lupus Erythematosus Causal Genetic Variant in the IRF5 Risk Locus
Guojun Hou, Tian Zhou, Ning Xu, et al.
Frontiers in Immunology
|
May 28, 2019
Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis
Zhuojun Liao, Zhizhong Ye, Zhixin Xue, et al.
Gut
|
February 11, 2016
Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis
Yingcheng Yang, Ximeng Lin, Xinyuan Lu, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2015
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 17, 2016
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors
Peilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Page
of 5